Semaglutide for weight loss in teens with autism
Part of Hormones & metabolism, Mental health clinical trials.
This study tests whether semaglutide (a once-weekly injection that helps with weight loss) can help teenagers with autism who are obese. It will compare their results to similar teens who did not take the drug to see if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 18 years old.
- You must have a diagnosis of autism spectrum disorder.
- You must have obesity, which means your body mass index (BMI) is at or above the 95th percentile for your age and sex.
- You must have insurance (like Medicaid) that covers semaglutide, or your parent must be willing to pay for it.
- Your parent or guardian must agree to you joining the study.
- You must be able to attend check-ups (in person or by video) for 12 months, and you must speak English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study looks at the experiences of people using injectable semaglutide for weight loss, as well as the doctors who prescribe it. It aims to understand how the treatment works in everyday life.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.